Bausch Health Companies Inc.
$22.19B- Market cap
- $2.45B
- Debt
- +$21.04B
- Cash
- −$1.31B
Capital structure 10% equity / 90% debt · EV / Revenue 2.16x · EV / EBITDA 9.16x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: BHC stock price vs OKE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OKE's multiple
Needs OKE P/E.
Implied fair value · at BHC's multiple
Needs BHC P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BHC FY 2025 (ended Dec 31, 2025) · OKE FY 2025 (ended Dec 31, 2025).
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 10% equity / 90% debt · EV / Revenue 2.16x · EV / EBITDA 9.16x
Capital structure 65% equity / 35% debt · EV / Revenue 2.74x · EV / EBITDA 11.97x
OKE carries the larger enterprise value at $92.07B against $22.19B; BHC trades on the lower EV / Revenue multiple (2.16x vs 2.74x); BHC on the lower EV / EBITDA (9.16x vs 11.97x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Bausch Health Companies Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ONEOK INC /NEW/ · implied price per share
Bear
$4.32
Base
$15.37
Bull
$30.29
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-37.98x
1.42x
Net debt / EBITDA
Leverage against operating earnings
8.15x
4.15x
Cash and equivalents
Liquid reserves on the balance sheet
$1.31B
$78.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$21.04B
$32.00B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.